These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 39098554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
    Luo Y, Li C, Zhang Y, Liu P, Chen H, Zhao Z, Wang Y, Zhou Z, Song H, Su B, Li C, Li X, Zhang T, You H, Wu Y, Tian Z, Zhang S, Guo Y, Fan H, Chen Q, Jiang C, Sun T.
    Acta Biomater; 2023 Sep 01; 167():387-400. PubMed ID: 37276955
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer.
    Chen X, Zhou W, Liang C, Shi S, Yu X, Chen Q, Sun T, Lu Y, Zhang Y, Guo Q, Li C, Zhang Y, Jiang C.
    Nano Lett; 2019 Jun 12; 19(6):3527-3534. PubMed ID: 31058513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
    Xiao H, Li X, Li B, Zhong Y, Qin J, Wang Y, Han S, Ren J, Shuai X.
    Acta Biomater; 2023 Apr 15; 161():265-274. PubMed ID: 36893956
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
    Ji T, Lang J, Wang J, Cai R, Zhang Y, Qi F, Zhang L, Zhao X, Wu W, Hao J, Qin Z, Zhao Y, Nie G.
    ACS Nano; 2017 Sep 26; 11(9):8668-8678. PubMed ID: 28806504
    [Abstract] [Full Text] [Related]

  • 10. Polymeric Micelles of PEG-PLA Copolymer as a Carrier for Salinomycin Against Gemcitabine-Resistant Pancreatic Cancer.
    Daman Z, Montazeri H, Azizi M, Rezaie F, Ostad SN, Amini M, Gilani K.
    Pharm Res; 2015 Nov 26; 32(11):3756-67. PubMed ID: 26228105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency.
    Chen D, Zhu X, Tao W, Kong Y, Huag Y, Zhang Y, Liu R, Jiang L, Tang Y, Yu H, Hao Q, Yang X, Zou H, Chen J, Lu Y, Zhang H, Li W.
    J Control Release; 2020 Aug 10; 324():545-559. PubMed ID: 32504777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.
    Dangi-Garimella S, Krantz SB, Barron MR, Shields MA, Heiferman MJ, Grippo PJ, Bentrem DJ, Munshi HG.
    Cancer Res; 2011 Feb 01; 71(3):1019-28. PubMed ID: 21148071
    [Abstract] [Full Text] [Related]

  • 20. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF, Jiang SH, Hu LP, Huang PQ, Wang X, Li J, Zhang XL, Nie HZ, Zhang ZG.
    Chin Clin Oncol; 2019 Apr 01; 8(2):18. PubMed ID: 31070038
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.